Database error: Access denied for user: 'dbo210286027@%' to database 'db210286027'
SQL: INSERT IGNORE INTO `wp_firestats_useragents` (`useragent`,`md5`) VALUES ('CCBot/1.0 (+http://www.commoncrawl.org/bot.html)',MD5(`useragent`))

medTRIALS.info

Translating Research into Treatment

FDA approves medicine for blood clots

Filed under: Prevention, All Cancers, Clinical Trials. Venous Thromboembolism, also know as a blood clot, is something that cancer patients should be aware. There is now a medicine approved for recurrent blood clots by the Food and Drug …
Original post by Kristina Collins delivered by Medtrials and StudyMe

HOUSTON, July 9, 2007 - A molecularly engineered therapy selectively embeds a gene in pancreatic cancer that shrinks or eradicates tumors, inhibits metastasis, and prolongs survival with virtually no toxicity, researchers from The…
Original post by unknown delivered by Medtrials and StudyMe

National Lung Cancer Partnership is offering a patient education booklet for those recently diagnosed with lung cancer and a patient education video that explores making the decision to enter a lung cancer clinical trial.
Original post by Debi delivered by Medtrials and StudyMe

BioCryst Pharmaceuticals Inc. today said the Food and Drug Administration has agreed to provide feedback on the design of a clinical trial for oral doses of Fodosine, the Birmingham biotechnology company’s most promising cancer drug …
Original post by bn_junderwood@al.com delivered by Medtrials and StudyMe

Scientists at the ESMO Conference Lugano (ECLU) in Switzerland announced the results of a clinical trial of NV1020, a virus developed from herpes simplex virus. NV1020 is safe to normal tissue, but deadly to cancer. …
Original post by Banshi Talukdar delivered by Medtrials and StudyMe

(OTCBB:CGRB) today announced that positive Phase I and Phase II data on the Company’s prostate cancer drug candidate CB7630 (abiraterone acetate) were presented at the European…
Original post by unknown delivered by Medtrials and StudyMe

First prospective biomarker trial in non-small cell lung cancer - LOS ANGELES, July 09, 2007 /PRNewswire-FirstCall/ — Response Genetics, Inc. today announced that positive Phase III clinical data published in the July 1 issue of the …
Original post by unknown delivered by Medtrials and StudyMe

MARTINSRIED/MUNICH, Germany, July 9, 2007-A virus that has been specifically designed by scientists to be safe to normal tissue but deadly to cancer is showing early promise in a preliminary study, researchers said today at the ESMO …
Original post by unknown delivered by Medtrials and StudyMe

A virus that has been specifically designed by scientists to be safe to normal tissue but deadly to cancer is showing early promise in a preliminary study, researchers said today at the ESMO Conference Lugano (ECLU), Switzerland.
Original post by unknown delivered by Medtrials and StudyMe

Data Feed

Pro-Pharmaceuticals (PRW) updated the progress of its Phase II clinical trial for first-line treatment of metastatic, unresectable colorectal cancer patients who are unable to tolerate irinotecan and/or oxaliplatin, and its Phase II …
Original post by misstrade delivered by Medtrials and StudyMe

« Previous Entries